文献速递肝胆胰外科胃肠外科

经十二指肠壶腹部切除术治疗早期壶腹癌:单中心临床管理、组织病理学发现与长期结局

Transduodenal ampullectomy for early ampullary cancer: Clinical management, histopathological findings and long-term outcomes at a single center.
PubMed 文献 · Surgery · 2023-01-23

该单中心回顾性研究纳入了10例接受经十二指肠壶腹部切除术和11例接受保留幽门胰十二指肠切除术的早期壶腹癌患者,发现经十二指肠壶腹部切除术组手术时间更短、出血更少、住院更短且营养状态更好;对于高级别异型增生腺瘤或侵犯黏膜层的T1壶腹癌,5年生存率为100%,而侵犯Oddi括约肌的T1壶腹癌中位生存时间仅20.7个月。结论认为经十二指肠壶腹部切除术对经过选择的早期壶腹癌患者是可行且有效的。

要点

  • 经十二指肠壶腹部切除术适用于高级别异型增生腺瘤或侵犯黏膜层的T1壶腹癌。
  • 与保留幽门胰十二指肠切除术相比,经十二指肠壶腹部切除术围术期恢复更优。
  • 侵犯Oddi括约肌的T1壶腹癌预后较差,中位生存时间20.7个月。

核心结论

  • 经十二指肠壶腹部切除术对经过选择的早期壶腹癌患者(包括高级别异型增生腺瘤或侵犯黏膜层的T1壶腹癌)是可行且有效的手术方式。

研究设计与样本

  • 单中心回顾性研究,纳入2008年10月至2021年5月埼玉癌症中心10例接受经十二指肠壶腹部切除术和11例接受保留幽门胰十二指肠切除术的早期壶腹癌患者。

主要发现

  • 经十二指肠壶腹部切除术组手术时间更短(244分钟 vs 390分钟,P = .003)。
  • 经十二指肠壶腹部切除术组术中出血更少(67.5克 vs 774克,P = .006)。
  • 经十二指肠壶腹部切除术组术后住院时间更短(15天 vs 33天)。
  • 经十二指肠壶腹部切除术组术后体重下降更少(0.67% vs 8.95%,P = .021)。
  • 经十二指肠壶腹部切除术组CONUT评分更优(1.0 vs 2.1,P = .011),PNI评分更优(42.9 vs 40.9,P = .018)。

关键数值与推荐

  • 高级别异型增生腺瘤和侵犯黏膜层的T1壶腹癌组5年生存率为100%。
  • 侵犯Oddi括约肌的T1壶腹癌组中位生存时间为20.7个月(P = .0028)。

临床怎么用

  • 对于经过选择的早期壶腹癌患者,可考虑经十二指肠壶腹部切除术以改善围术期结局和术后营养状态。
  • 术前应仔细评估肿瘤浸润深度,侵犯Oddi括约肌的T1壶腹癌可能不适合经十二指肠壶腹部切除术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transduodenal ampullectomy has been attempted in ampullary tumors, including early ampullary cancer. However, the indication and extent of transduodenal ampullectomy with curative intent remain controversial. Herein, we address the perioperative and long-term outcomes of patients with early ampullary cancer who underwent transduodenal ampullectomy at a single center. METHODS: We retrospectively enrolled 10 early ampullary cancer patients who underwent transduodenal ampullectomy and 11 early ampullary cancer patients who underwent subtotal stomach-preserving pancreatoduodenectomy at Saitama Cancer Center between October 2008 and May 2021. Among this cohort, we analyzed the perioperative outcomes and long-term outcomes. RESULTS: In terms of the perioperative outcomes between the transduodenal ampullectomy and subtotal stomach-preserving pancreatoduodenectomy groups, the transduodenal ampullectomy group exhibited a shorter operating time (244 minutes vs 390 minutes, P = .003), less intraoperative blood loss (67.5 grams vs 774 grams, P = .006) and shorter length of postoperative hospital stay (15 days vs 33 days). With respect to the postoperative nutrition status, the transduodenal ampullectomy group exhibited less postoperative weight loss (0.67% vs 8.95%, P = .021), a better Controlling Nutritional Status score (1.0 vs 2.1, P = .011) and a better Prognostic Nutritional Index score (42.9 vs 40.9, P = .018). The 5-year survival in the adenoma with high-grade dysplasia and T1 ampullary cancer which invaded the mucosal layer groups was 100%, whereas the median survival time in the T1 ampullary cancer which invaded the sphincter of Oddi group was 20.7 months (P = .0028). CONCLUSION: Transduodenal ampullectomy is assumed to be a feasible and effective surgical procedure for the treatment of selected patients with early ampullary cancer, including patients with adenoma with high-grade dysplasia or T1 ampullary cancer which invaded the mucosal layer ampullary cancer.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Miyamoto R, Takahashi A, Ogura T, et al. Transduodenal ampullectomy for early ampullary cancer: Clinical management, histopathological findings and long-term outcomes at a single center. Surgery. 2023. PMID: 36697354. doi:10.1016/j.surg.2022.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。